A unit of MicroPort CardioFlow Medtech (HKG:2160) agreed to purchase the remaining 49% equity stake it does not already own in Shanghai MicroPort CardioAdvent for 170.9 million yuan, a Friday Hong Kong bourse filing said.
Shanghai MicroPort CardioFlow Medtech will buy a 35.27% stake from MicroPort Sinica and 13.73% from Shanghai Zuoqing Enterprise Management Consulting Service Centre.
Upon completion, it will own 100% of the target company, the filing said.
Shanghai MicroPort CardioAdvent is a high-tech medical device firm specializing in left atrial appendage devices.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.